The Lancet Oncology

The Lancet Oncology is the world-leading journal dedicated to clinical oncology research, covering topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. As an internationally trusted source of clinical, public health, and global health knowledge, with an Impact Factor of 54.433 (2021 Journal Citation Reports®, Clarivate 2022), we have also fostered a reputation for hosting events for oncologists, cancer researchers, and policymakers, and convene many conferences, either independently or in collaboration with partners. Events include branded plenary lectures and sessions at conferences worldwide. We publish a range of article types that encompass all aspects of oncological medicine: Articles, Review, Policy Review, Personal View, Clinical Picture, Comment, Correspondence, News, and Perspectives. As part of our flagship advocacy programme, we also publish Series and Commissions (typically in partnership with societies, governments, NGOs, and academic centres) that aim to shape and drive positive change in clinical practice and health policy in areas of need in global oncology.